{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:37:53Z","timestamp":1791221873119,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2025\/03\/35260"],"award-info":[{"award-number":["PSAU\/2025\/03\/35260"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11555-w","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T12:44:41Z","timestamp":1778330681000},"page":"8225-8251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Structure-guided design and synthesis of Etoricoxib analogues for selective COX-2 inhibition: in vitro assessment and computational insights with prospective in vivo confirmation"],"prefix":"10.1007","volume":"30","author":[{"given":"Mohammed H.","family":"Alqarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Elgohary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Abdelrahman","family":"Alkabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Foudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq M.","family":"Aljarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Elkotamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"11555_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-97-0157-5_1","volume-title":"Overview of inflammation. Inflammation resolution and chronic diseases","author":"D Chopra","year":"2024","unstructured":"Chopra D, Shukla S, Rana P, Kamar MD, Gaur P, Bala M, Pathaniya D (2024) Overview of inflammation. Inflammation resolution and chronic diseases. Springer, Berlin, pp 1\u201318"},{"issue":"11","key":"11555_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119647","volume":"24","author":"J-L Wautier","year":"2023","unstructured":"Wautier J-L, Wautier M-P (2023) Pro-and anti-inflammatory prostaglandins and cytokines in humans: a mini review. Int J Mol Sci 24(11):9647","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11555_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jiph.2023.04.014","volume":"16","author":"H-H Zhuang","year":"2023","unstructured":"Zhuang H-H, Chen Y, Hu Q, Long W-M, Wu X-L, Wang Q et al (2023) Efficacy and mortality of ceftazidime\/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: a retrospective multicenter observational study. J Infect Public Health 16(6):938\u2013947","journal-title":"J Infect Public Health"},{"issue":"6","key":"11555_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/molecules29061309","volume":"29","author":"NA Alshaye","year":"2024","unstructured":"Alshaye NA, Elgohary MK, Elkotamy MS, Abdel-Aziz HA (2024) Design, synthesis, and biological evaluation of novel phenoxy acetic acid derivatives as selective COX-2 inhibitors coupled with comprehensive bio-pharmacological inquiry, histopathological profiling, and toxicological scrutiny. Molecules 29(6):1309","journal-title":"Molecules"},{"issue":"5","key":"11555_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/18715281113129990053","volume":"12","author":"D Laveti","year":"2013","unstructured":"Laveti D, Kumar M, Hemalatha R, Sistla R, Naidu GmV, Talla V et al (2013) Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets 12(5):349\u2013361","journal-title":"Inflamm Allergy Drug Targets"},{"key":"11555_CR6","doi-asserted-by":"publisher","first-page":"137554","DOI":"10.1016\/j.ijbiomac.2024.137554","volume":"283","author":"MS Elkotamy","year":"2024","unstructured":"Elkotamy MS, Elgohary MK, Alkabbani MA, Salem R, Eldehna WM, Abdel-Aziz HA (2024) Spiro-fused indoline-quinazoline hybrids as smart bombs against TNF-\u03b1-mediated inflammation. Int J Biol Macromol 283:137554","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"11555_CR7","first-page":"559","volume":"13","author":"RE Harris","year":"2005","unstructured":"Harris RE, Beebe-Donk J, Doss H, Doss DB (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade. Oncol Rep 13(4):559\u2013583","journal-title":"Oncol Rep"},{"issue":"15","key":"11555_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2174\/1389557516666160505115743","volume":"16","author":"T Yu","year":"2016","unstructured":"Yu T, Lao X, Zheng H (2016) Influencing COX-2 activity by COX related pathways in inflammation and cancer. Mini Rev Med Chem 16(15):1230\u20131243","journal-title":"Mini Rev Med Chem"},{"issue":"11","key":"11555_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1080\/14740338.2024.2396387","volume":"24","author":"R Li","year":"2025","unstructured":"Li R, Luo P, Guo Y, He Y, Wang C (2025) Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis. Expert Opin Drug Saf 24(11):1253\u20131257","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"11555_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/08923973.2024.2402338","volume":"46","author":"Y He","year":"2024","unstructured":"He Y, Fan Z, Sun W, Ouyang L, Wang C (2024) Clinical features, treatment, and outcome of nivolumab-induced cholangitis. Immunopharmacol Immunotoxicol 46(6):757\u2013762","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"11555_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00228-007-0400-7","volume":"64","author":"S Shi","year":"2008","unstructured":"Shi S, Klotz U (2008) Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol 64(3):233\u2013252","journal-title":"Eur J Clin Pharmacol"},{"key":"11555_CR12","doi-asserted-by":"publisher","first-page":"107393","DOI":"10.1016\/j.bioorg.2024.107393","volume":"147","author":"MK Elgohary","year":"2024","unstructured":"Elgohary MK, Elkotamy MS, Abdelrahman Alkabbani M, Abdel-Aziz HA (2024) Fenamates and ibuprofen as foundational components in the synthesis of innovative, targeted COX-2 anti-inflammatory drugs, undergoing thorough biopharmacological assessments and in-silico computational studies. Bioorg Chem 147:107393. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107393","journal-title":"Bioorg Chem"},{"issue":"9","key":"11555_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00011-020-01368-4","volume":"69","author":"L Tang","year":"2020","unstructured":"Tang L, Chen Y, Xiang Q, Xiang J, Tang Y, Li J (2020) The association between IL18, FOXP3 and IL13 genes polymorphisms and risk of allergic rhinitis: a meta-analysis. Inflamm Res 69(9):911\u2013923","journal-title":"Inflamm Res"},{"issue":"1","key":"11555_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0006-291X(02)02996-0","volume":"301","author":"AD Pillai","year":"2003","unstructured":"Pillai AD, Rathod PD, Patel M, Nivsarkar M, Vasu KK, Padh H, Sudarsanam V (2003) Novel drug designing approach for dual inhibitors as anti-inflammatory agents: implication of pyridine template. Biochem Biophys Res Commun 301(1):183\u2013186","journal-title":"Biochem Biophys Res Commun"},{"key":"11555_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bioorg.2016.12.008","volume":"70","author":"SS Alsayed","year":"2017","unstructured":"Alsayed SS, Elshemy HA, Abdelgawad MA, Abdel-Latif MS, Abdellatif KR (2017) Design, synthesis and biological screening of some novel Celecoxib and Etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem 70:173\u2013183","journal-title":"Bioorg Chem"},{"issue":"6","key":"11555_CR16","first-page":"306","volume":"6","author":"HH Abdu-Allah","year":"2016","unstructured":"Abdu-Allah HH, El-Shorbagi A, Abdel-Moty SG, El-Awady R, Abdel-Alim A (2016) 5-Aminosalyclic acid (5-ASA): a unique anti-inflammatory salicylate. Med Chem (Los Angeles) 6(6):306\u2013315","journal-title":"Med Chem (Los Angeles)"},{"issue":"2","key":"11555_CR17","doi-asserted-by":"publisher","first-page":"81s","DOI":"10.18433\/J3T886","volume":"11","author":"P Rao","year":"2008","unstructured":"Rao P, Knaus EE (2008) Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 11(2):81s\u2013110s","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"11555_CR18","doi-asserted-by":"publisher","first-page":"2000328","DOI":"10.1002\/ardp.202000328","volume":"354","author":"KR Abdellatif","year":"2021","unstructured":"Abdellatif KR, Abdelall EK, Elshemy HA, El\u2010Nahass ES, Abdel\u2010Fattah MM, Abdelgawad YY (2021) New Indomethacin analogs as selective COX\u20102 inhibitors: synthesis, COX\u20101\/2 inhibitory activity, anti\u2010inflammatory, ulcerogenicity, histopathological, and docking studies. Arch Pharm 354(4):2000328","journal-title":"Arch Pharm"},{"issue":"28","key":"11555_CR19","doi-asserted-by":"publisher","first-page":"e202103228","DOI":"10.1002\/slct.202103228","volume":"7","author":"A Almasirad","year":"2022","unstructured":"Almasirad A, Sani PSV, Mousavi Z, Fard GB, Anvari T, Farhadi M et al (2022) Novel thiazolotriazolone derivatives: design, synthesis, in silico investigation, analgesic and anti\u2010inflammatory activity. ChemistrySelect 7(28):e202103228","journal-title":"ChemistrySelect"},{"issue":"3","key":"11555_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1042\/BJ20031859","volume":"384","author":"S Rahmouni","year":"2004","unstructured":"Rahmouni S, Aandahl EM, Nayjib B, Zeddou M, Giannini S, Verlaet M et al (2004) Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem J 384(3):469\u2013476","journal-title":"Biochem J"},{"issue":"1","key":"11555_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/13543776.15.1.9","volume":"15","author":"S Chung","year":"2005","unstructured":"Chung S, Lim KM, Shin SS (2005) Profiles of COX-2 inhibitors: present and future. Expert Opin Ther Pat 15(1):9\u201332","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"11555_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0022-3565(24)38776-2","volume":"296","author":"D Riendeau","year":"2001","unstructured":"Riendeau D, Percival M, Brideau C, Charleson S, Dube D, Ethier D et al (2001) Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 296(2):558\u2013566","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"11555_CR23","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1074\/jbc.M113.517987","volume":"289","author":"S Xu","year":"2014","unstructured":"Xu S, Hermanson DJ, Banerjee S, Ghebreselasie K, Clayton GM, Garavito RM, Marnett LJ (2014) Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding network. J Biol Chem 289(10):6799\u20136808","journal-title":"J Biol Chem"},{"key":"11555_CR24","doi-asserted-by":"publisher","first-page":"114712","DOI":"10.1016\/j.ejmech.2022.114712","volume":"243","author":"ZT Gannam","year":"2022","unstructured":"Gannam ZT, Jamali H, Kweon OS, Herrington J, Shillingford SR, Papini C et al (2022) Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors. Eur J Med Chem 243:114712","journal-title":"Eur J Med Chem"},{"key":"11555_CR25","doi-asserted-by":"publisher","first-page":"140462","DOI":"10.1016\/j.ijbiomac.2025.140462","volume":"303","author":"MS Elkotamy","year":"2025","unstructured":"Elkotamy MS, Abdelrahman MA, Giovannuzzi S, Alkabbani MA, Nocentini A, Supuran CT et al (2025) Development of pyrazolo [1, 5-a] pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity. Int J Biol Macromol 303:140462","journal-title":"Int J Biol Macromol"},{"key":"11555_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.molstruc.2016.07.043","volume":"1125","author":"M Zahedifar","year":"2016","unstructured":"Zahedifar M, Razavi R, Sheibani H (2016) Reaction of (chloro carbonyl) phenyl ketene with 5-amino pyrazolones: Synthesis, characterization and theoretical studies of 7-hydroxy-6-phenyl-3-(phenyldiazenyl) pyrazolo [1, 5-a] pyrimidine-2, 5 (1H, 4H)-dione derivatives. J Mol Struct 1125:730\u2013735","journal-title":"J Mol Struct"},{"key":"11555_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117752","author":"MS Elkotamy","year":"2025","unstructured":"Elkotamy MS, Elkelesh IA, Giovannuzzi S, Ismail RS, El-Refaie WM, Almehizia AA et al (2025) Rationally designed Pyrazolo [1, 5-a] pyrimidines as dual inhibitors of CA IX\/XII and CDK6: a novel approach for NSCLC treatment. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117752","journal-title":"Eur J Med Chem"},{"key":"11555_CR28","doi-asserted-by":"publisher","first-page":"107644","DOI":"10.1016\/j.bioorg.2024.107644","volume":"151","author":"MS Elkotamy","year":"2024","unstructured":"Elkotamy MS, Elgohary MK, Al-Rashood ST, Almahli H, Eldehna WM, Abdel-Aziz HA (2024) Novel imidazo [2, 1-b] thiazoles and imidazo [1, 2-a] pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: Design, synthesis and biological evaluations. Bioorg Chem 151:107644","journal-title":"Bioorg Chem"},{"key":"11555_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2025.2475233","author":"MS Elkotamy","year":"2025","unstructured":"Elkotamy MS, Elgohary MK, Alkabbani MA, Binjubair FA, Alanazi MM, Alsulaimany M et al (2025) Design, synthesis and biological evaluation of Pyrazolo [3, 4-b] pyridine derivatives as dual CDK2\/PIM1 inhibitors with potent anti-cancer activity and selectivity. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2025.2475233","journal-title":"J Biomol Struct Dyn"},{"key":"11555_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejmech.2015.03.025","volume":"95","author":"C Beinat","year":"2015","unstructured":"Beinat C, Reekie T, Banister SD, O\u2019Brien-Brown J, Xie T, Olson TT et al (2015) Structure\u2013activity relationship studies of SEN12333 analogues: determination of the optimal requirements for binding affinities at \u03b17 nAChRs through incorporation of known structural motifs. Eur J Med Chem 95:277\u2013301","journal-title":"Eur J Med Chem"},{"issue":"9","key":"11555_CR31","doi-asserted-by":"publisher","first-page":"e0308036","DOI":"10.1371\/journal.pone.0308036","volume":"19","author":"M Shahedi","year":"2024","unstructured":"Shahedi M, Shahani R, Omidi N, Habibi Z, Yousefi M, Mohammadi M (2024) Laccase-mediated chemoselective C-4 arylation of 5-aminopyrazoles. PLoS ONE 19(9):e0308036","journal-title":"PLoS ONE"},{"issue":"10","key":"11555_CR32","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1021\/cr2002992","volume":"111","author":"WL Smith","year":"2011","unstructured":"Smith WL, Urade Y, Jakobsson P-J (2011) Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev 111(10):5821\u20135865","journal-title":"Chem Rev"},{"issue":"20","key":"11555_CR33","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1080\/17568919.2025.2561543","volume":"17","author":"MK Elgohary","year":"2025","unstructured":"Elgohary MK, Elkotamy MS, Alkabbani MA, El-Khatib AM, Ibrahim AMA, Alshabi AM et al (2025) Design and evaluation of 2-(4-((2-(2-((2, 6-dichloro-3-methylphenyl) amino) benzoyl) hydrazineylidene) methyl) phenoxy) acetic acid as a dual anti-inflammatory and anti-diabetic agent. Future Med Chem 17(20):2453\u20132464","journal-title":"Future Med Chem"},{"issue":"4","key":"11555_CR34","first-page":"631","volume":"2","author":"MA Alkabbani","year":"2023","unstructured":"Alkabbani MA, Amer WA, Mustafa AM, Faheem SA (2023) The potential protective effect of Vildagliptin on Paw Edema: an experimental study. ERU Res J 2(4):631\u2013647","journal-title":"ERU Res J"},{"issue":"11","key":"11555_CR35","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1007\/s00044-011-9895-7","volume":"21","author":"K Abouzid","year":"2012","unstructured":"Abouzid K, Khalil N, Ahmed E, Esmat A, Al-Abd A (2012) Design, synthesis, and evaluation of anti-inflammatory and ulcerogenicity of novel pyridazinone derivatives. Med Chem Res 21(11):3581\u20133590","journal-title":"Med Chem Res"},{"issue":"2","key":"11555_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020344","volume":"19","author":"MM Abdel-Daim","year":"2018","unstructured":"Abdel-Daim MM, Eltaysh R, Hassan A, Mousa SA (2018) Lycopene attenuates tulathromycin and diclofenac sodium-induced cardiotoxicity in mice. Int J Mol Sci 19(2):344","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11555_CR37","doi-asserted-by":"publisher","first-page":"e04141","DOI":"10.1016\/j.heliyon.2020.e04141","volume":"6","author":"LS Li","year":"2020","unstructured":"Li LS, Chiroma SM, Hashim T, Adam SK, Mohd Moklas MA, Yusuf Z, Rahman SA (2020) Antioxidant and anti-inflammatory properties of Erythroxylum cuneatum alkaloid leaf extract. Heliyon 6(6):e04141. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04141","journal-title":"Heliyon"},{"issue":"3","key":"11555_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.22037\/ijpr.2020.1101154","volume":"19","author":"SA Hamdy","year":"2020","unstructured":"Hamdy SA, Menze ET, El Hefnawy HM, Azzam SM, Aboutabl EA (2020) In-vivo anti-inflammatory activity of Hydrocotyle umbellata L. aerial parts and isolation of the main phytochemicals. Iran J Pharm Res 19(3):34\u201344. https:\/\/doi.org\/10.22037\/ijpr.2020.1101154","journal-title":"Iran J Pharm Res"},{"key":"11555_CR39","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ijbiomac.2014.09.059","volume":"72","author":"HK Solanki","year":"2015","unstructured":"Solanki HK, Shah DA, Maheriya PM, Patel CA (2015) Evaluation of anti-inflammatory activity of probiotic on carrageenan-induced paw edema in Wistar rats. Int J Biol Macromol 72:1277\u20131282. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.09.059","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"11555_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4103\/0253-7613.157127","volume":"47","author":"MT Mansouri","year":"2015","unstructured":"Mansouri MT, Hemmati AA, Naghizadeh B, Mard SA, Rezaie A, Ghorbanzadeh B (2015) A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian J Pharmacol 47(3):292\u2013298. https:\/\/doi.org\/10.4103\/0253-7613.157127","journal-title":"Indian J Pharmacol"},{"issue":"12","key":"11555_CR41","doi-asserted-by":"publisher","first-page":"23980","DOI":"10.3390\/ijms141223980","volume":"14","author":"Y Ma","year":"2013","unstructured":"Ma Y, Li Y, Li X, Wu Y (2013) Anti-inflammatory effects of 4-methylcyclopentadecanone on edema models in mice. Int J Mol Sci 14(12):23980\u201323992. https:\/\/doi.org\/10.3390\/ijms141223980","journal-title":"Int J Mol Sci"},{"issue":"10","key":"11555_CR42","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918\u2013935","journal-title":"Curr Neuropharmacol"},{"key":"11555_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00071","volume":"5","author":"D Bhatt","year":"2014","unstructured":"Bhatt D, Ghosh S (2014) Regulation of the NF-\u03baB-mediated transcription of inflammatory genes. Front Immunol 5:71","journal-title":"Front Immunol"},{"issue":"42","key":"11555_CR44","doi-asserted-by":"publisher","first-page":"38658","DOI":"10.1074\/jbc.M106599200","volume":"276","author":"B Poligone","year":"2001","unstructured":"Poligone B, Baldwin AS (2001) Positive and negative regulation of NF-\u03baB by COX-2: roles of different prostaglandins. J Biol Chem 276(42):38658\u201338664","journal-title":"J Biol Chem"},{"issue":"4","key":"11555_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/1568010054526359","volume":"4","author":"R Korhonen","year":"2005","unstructured":"Korhonen R, Lahti A, Kankaanranta H, Moilanen E (2005) Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4(4):471\u2013479","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"1","key":"11555_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/1874210601913010332","volume":"13","author":"LB Silva","year":"2019","unstructured":"Silva LB, dos Santos Neto AP, Maia SM, dos Santos Guimar\u00e3es C, Quidute IL, Carvalho AA et al (2019) The role of TNF-\u03b1 as a proinflammatory cytokine in pathological processes. Open Dent J 13(1):332\u2013338","journal-title":"Open Dent J"},{"key":"11555_CR47","doi-asserted-by":"publisher","first-page":"613170","DOI":"10.3389\/fimmu.2020.613170","volume":"11","author":"K Pyrillou","year":"2020","unstructured":"Pyrillou K, Burzynski LC, Clarke MC (2020) Alternative pathways of IL-1 activation, and its role in health and disease. Front Immunol 11:613170","journal-title":"Front Immunol"},{"issue":"1","key":"11555_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2010.08.030","volume":"647","author":"AS Mohamad","year":"2010","unstructured":"Mohamad AS, Akhtar MN, Zakaria ZA, Perimal EK, Khalid S, Mohd PA et al (2010) Antinociceptive activity of a synthetic chalcone, flavokawin B on chemical and thermal models of nociception in mice. Eur J Pharmacol 647(1):103\u2013109. https:\/\/doi.org\/10.1016\/j.ejphar.2010.08.030","journal-title":"Eur J Pharmacol"},{"key":"11555_CR49","doi-asserted-by":"publisher","first-page":"105726","DOI":"10.1016\/j.bioorg.2022.105726","volume":"122","author":"DH Dawood","year":"2022","unstructured":"Dawood DH, Nossier ES, Abdelhameed MF, Asaad GF, Abd El-Rahman SS (2022) Design, synthesis, anti-inflammatory evaluation and molecular docking of novel thiophen-2-ylmethylene-based derivatives as potential TNF-\u03b1 production inhibitors. Bioorg Chem 122:105726. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105726","journal-title":"Bioorg Chem"},{"key":"11555_CR50","doi-asserted-by":"publisher","first-page":"131404","DOI":"10.1016\/j.molstruc.2021.131404","volume":"1247","author":"M Ph","year":"2022","unstructured":"Ph M, Al-Ostoot FH, Vivek HK, Khanum SA (2022) Design, docking, synthesis, and characterization of novel N\u2019(2-phenoxyacetyl) nicotinohydrazide and N\u2019(2-phenoxyacetyl)isonicotinohydrazide derivatives as anti-inflammatory and analgesic agents. J Mol Struct 1247:131404. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131404","journal-title":"J Mol Struct"},{"key":"11555_CR51","doi-asserted-by":"publisher","first-page":"8935085","DOI":"10.1155\/2017\/8935085","volume":"2017","author":"MA Hijazi","year":"2017","unstructured":"Hijazi MA, El-Mallah A, Aboul-Ela M, Ellakany A (2017) Evaluation of analgesic activity of Papaver libanoticum extract in mice: involvement of opioids receptors. Evid Based Complement Alternat Med 2017:8935085. https:\/\/doi.org\/10.1155\/2017\/8935085","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"11555_CR52","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1007\/s10787-023-01327-5","volume":"31","author":"KM Ibrahim","year":"2023","unstructured":"Ibrahim KM, Ahmed HI, Ramadan L, Balah A (2023) A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4\/NF-\u03baB and Nrf2\/HO-1 signaling pathways. Inflammopharmacology 31(5):2467\u20132478. https:\/\/doi.org\/10.1007\/s10787-023-01327-5","journal-title":"Inflammopharmacology"},{"key":"11555_CR53","doi-asserted-by":"publisher","first-page":"109297","DOI":"10.1016\/j.intimp.2022.109297","volume":"113","author":"SS Sokar","year":"2022","unstructured":"Sokar SS, Alkabbani MA, Akool E-S, Abu-Risha SE-S (2022) Hepatoprotective effects of carvedilol and crocin against leflunomide-induced liver injury. Int Immunopharmacol 113:109297. https:\/\/doi.org\/10.1016\/j.intimp.2022.109297","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"11555_CR54","first-page":"1540","volume":"3","author":"MA Alkabbani","year":"2024","unstructured":"Alkabbani MA, Shatat A-AS, Ghazy AN, Magdy K (2024) Chemotherapy-induced liver injury: unveiling emerging mechanisms and exploring mitigation strategies. ERU Res J 3(4):1540\u20131567","journal-title":"ERU Res J"},{"key":"11555_CR55","doi-asserted-by":"publisher","first-page":"117392","DOI":"10.1016\/j.ejmech.2025.117392","volume":"288","author":"RZ Batran","year":"2025","unstructured":"Batran RZ, Ebaid MS, Nasralla SN, Son NT, Ha NX, Abdelsattar Ibrahim HA et al (2025) Synthesis and mechanistic insights of Coumarinyl-Indolinone hybrids as potent inhibitors of Leishmania major. Eur J Med Chem 288:117392. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117392","journal-title":"Eur J Med Chem"},{"key":"11555_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04334-1","author":"AE Elsisi","year":"2025","unstructured":"Elsisi AE, Abu-Risha SE-S, Alkabbani MA, Ramadan LA, Sokar SS (2025) Balancing efficacy and hepatotoxicity: a comprehensive review of oral medications in psoriasis management. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04334-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"11555_CR57","doi-asserted-by":"publisher","first-page":"31629","DOI":"10.1038\/s41598-025-16740-9","volume":"15","author":"SS Sokar","year":"2025","unstructured":"Sokar SS, Abu-Risha SE, Alkabbani MA, Ramadan LA, Elsisi AE (2025) Protective effects of melatonin and naringenin against acitretin induced hepatotoxicity via modulation of oxidative stress and inflammatory signaling. Sci Rep 15(1):31629. https:\/\/doi.org\/10.1038\/s41598-025-16740-9","journal-title":"Sci Rep"},{"issue":"2","key":"11555_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/ftd.0000000000000589","volume":"41","author":"BR Griffin","year":"2019","unstructured":"Griffin BR, Faubel S, Edelstein CL (2019) Biomarkers of drug-induced kidney toxicity. Ther Drug Monit 41(2):213\u2013226. https:\/\/doi.org\/10.1097\/ftd.0000000000000589","journal-title":"Ther Drug Monit"},{"issue":"5","key":"11555_CR59","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.ajkd.2021.04.016","volume":"78","author":"LA Inker","year":"2021","unstructured":"Inker LA, Titan S (2021) Measurement and estimation of GFR for use in clinical practice: core curriculum 2021. Am J Kidney Dis 78(5):736\u2013749. https:\/\/doi.org\/10.1053\/j.ajkd.2021.04.016","journal-title":"Am J Kidney Dis"},{"key":"11555_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04920-3","author":"WA Elkady","year":"2026","unstructured":"Elkady WA, Faheem SA, Hazem RM, El-Orabi NF (2026) Praziquantel ameliorates leflunomide-induced nephrotoxicity in mice: a novel therapeutic approach targeting TGF-\u03b2\/Smad\/Wnt\/\u03b2-catenin\/NF-\u03baB\/PPAR-\u03b3 signaling and Nrf-2. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04920-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"11555_CR61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.21037\/atm.2016.05.19","volume":"4","author":"E Danese","year":"2016","unstructured":"Danese E, Montagnana M (2016) An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med 4(10):194. https:\/\/doi.org\/10.21037\/atm.2016.05.19","journal-title":"Ann Transl Med"},{"key":"11555_CR62","doi-asserted-by":"publisher","first-page":"096032712311986","DOI":"10.1177\/09603271231198624","volume":"42","author":"RM Elmorsi","year":"2023","unstructured":"Elmorsi RM, El Saadany AA, Kabel AM, Abou El-Seoud SH (2023) The protective effects of topiramate and spirulina against doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol 42:09603271231198624. https:\/\/doi.org\/10.1177\/09603271231198624","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"11555_CR63","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717","journal-title":"Sci Rep"},{"issue":"4","key":"11555_CR64","first-page":"177","volume":"3","author":"S Nhlapho","year":"2024","unstructured":"Nhlapho S, Nyathi MHL, Ngwenya BL, Dube T, Telukdarie A, Munien I et al (2024) Druggability of pharmaceutical compounds using Lipinski rules with machine learning. Sci Pharm 3(4):177\u2013192","journal-title":"Sci Pharm"},{"issue":"1","key":"11555_CR65","doi-asserted-by":"publisher","first-page":"e70211","DOI":"10.1002\/ddr.70211","volume":"87","author":"MK Elgohary","year":"2026","unstructured":"Elgohary MK, Elkotamy MS, Elsayed ZM, Abdelraheem AM, Radwan IT, Darweish E et al (2026) Rational design of triazole hydrazide derivatives with imidazo [2, 1-b] thiazole scaffolds as targeted EGFR inhibitors in NSCLC. Drug Dev Res 87(1):e70211","journal-title":"Drug Dev Res"},{"key":"11555_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146776","author":"WM Eldehna","year":"2025","unstructured":"Eldehna WM, Elbadawi MM, Elsayed ZM, Giovannuzzi S, Elkotamy MS, Elsawi AE et al (2025) 2-(Piperidin-1-yl)-N-(4-sulfamoylphenyl) acetamide derivatives as novel inhibitors of cancer-associated carbonic anhydrase isoforms IX and XII. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146776","journal-title":"Int J Biol Macromol"},{"key":"11555_CR67","doi-asserted-by":"publisher","first-page":"136634","DOI":"10.1016\/j.molstruc.2023.136634","volume":"1295","author":"PR Krishnendu","year":"2024","unstructured":"Krishnendu PR, Benny S, Kumar S, Jayan J, Bhaskar V, Pappachen LK et al (2024) A structure-based approach to explore novel COX-2 inhibitors using pharmacophore modelling, 3D-QSAR analysis, virtual screening and dynamics simulation study. J Mol Struct 1295:136634","journal-title":"J Mol Struct"},{"issue":"5","key":"11555_CR68","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/med.20067","volume":"26","author":"H Alonso","year":"2006","unstructured":"Alonso H, Bliznyuk AA, Gready JE (2006) Combining docking and molecular dynamic simulations in drug design. Med Res Rev 26(5):531\u2013568","journal-title":"Med Res Rev"},{"key":"11555_CR69","doi-asserted-by":"publisher","first-page":"108247","DOI":"10.1016\/j.bioorg.2025.108247","volume":"157","author":"MS Elkotamy","year":"2025","unstructured":"Elkotamy MS, Elgohary MK, Elkelesh IA, Alkabbani MA, Khaleel EF, Eldehna WM, Abdel-Aziz HA (2025) Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles. Bioorg Chem 157:108247","journal-title":"Bioorg Chem"},{"key":"11555_CR70","doi-asserted-by":"publisher","first-page":"117158","DOI":"10.1016\/j.ejmech.2024.117158","volume":"283","author":"MS Elkotamy","year":"2025","unstructured":"Elkotamy MS, Elgohary MK, Alkabbani MA, Hefina MM, Tawfik HO, Fares M et al (2025) Design, synthesis, and evaluation of novel benzofuran and pyrazole-based derivatives as dual AChE\/BuChE inhibitors with antioxidant properties for Alzheimer\u2019s disease management. Eur J Med Chem 283:117158","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11555-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:02:56Z","timestamp":1791126176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11555-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11555"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11555-w","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}